Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Viral Hepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00596960
What this trial is testing

Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients

Who this might be right for
Alcohol DependenceChronic Hepatitis C
US Department of Veterans Affairs 139
Post-approval studies (Phase 4)Study completedNCT05753280
What this trial is testing

Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHB

Who this might be right for
Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University 90
Not applicableStudy completedNCT03071133
What this trial is testing

Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 344
Testing effectiveness (Phase 2)Study completedNCT02726789
What this trial is testing

Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 5
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Not applicableStudy completedNCT05317260
What this trial is testing

Steatohepatitis in Chronic Hepatitis B

Who this might be right for
Fatty LiverChronic Hepatitis b
Mahidol University 408
Post-approval studies (Phase 4)Study completedNCT03471624
What this trial is testing

Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)

Who this might be right for
Hepatitis B, Chronic
Stanford University 270
Post-approval studies (Phase 4)UnknownNCT00921180
What this trial is testing

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
National Taiwan University Hospital 148
Testing effectiveness (Phase 2)Study completedNCT01204762
What this trial is testing

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Who this might be right for
Hepatitis B Virus
Bristol-Myers Squibb 197
Large-scale testing (Phase 3)Study completedNCT01616524
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb 880
Testing effectiveness (Phase 2)Study completedNCT00944684
What this trial is testing

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Bern 32
Early research (Phase 1)Study completedNCT00959933
What this trial is testing

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

Who this might be right for
Chronic Hepatitis C
Sandoz 24
Post-approval studies (Phase 4)UnknownNCT03801538
What this trial is testing

The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Not applicableStudy completedNCT00983164
What this trial is testing

Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical Trial

Who this might be right for
Hepatitis COxidative Stress
Universidade do Sul de Santa Catarina 32
Large-scale testing (Phase 3)Study completedNCT02220998
What this trial is testing

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 269
Testing effectiveness (Phase 2)Study completedNCT04856085
What this trial is testing

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Vir Biotechnology, Inc. 244
Not applicableNot Yet RecruitingNCT07053449
What this trial is testing

The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms

Who this might be right for
Hepatitis B Virus (HBV)
Nottingham University Hospitals NHS Trust 30
Early research (Phase 1)Not Yet RecruitingNCT07589400
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver DiseaseChronic Hepatitis b
Xiamen Amoytop Biotech Co., Ltd. 24
Large-scale testing (Phase 3)WithdrawnNCT01296971
What this trial is testing

The Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche
Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27
Next Page